XML 98 R85.htm IDEA: XBRL DOCUMENT v3.20.4
Equity and Cash Incentive Program (Details) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Stock-based compensation expense [Abstract]      
Pre-tax compensation expense $ 25,026 $ 29,702 $ 23,698
Tax benefit (2,731) (2,490) (2,722)
Total stock-based compensation expense, net of tax $ 22,295 $ 27,212 $ 20,976
Awards Granted, Fair Value Assumptions and Methodology [Abstract]      
Shares available for grant 17,000,000    
Vesting period (in years) 3 years    
Award term 10 years    
Shares Granted to Directors [Abstract]      
Share Based Goods and Nonemployee Services Transaction Aggregate Shares Granted 9,854 10,838 15,802
Shares deferred (6,278) (6,168) (9,917)
Net shares granted 3,576 4,670 5,885
Stock Appreciation Rights (SARs) [Member]      
Awards Granted, Fair Value Assumptions and Methodology [Abstract]      
Additional awards issued due to modification     1,138,008
Risk-free interest rate (in hundredths) 1.44% 2.51%  
Dividend yield (in hundredths) 1.65% 2.13%  
Expected life (in years) 5 years 6 months 5 years 7 months 6 days  
Volatility (in hundredths) 22.76% 22.35%  
Grant price $ 119.86 $ 91.20  
Fair value on date of grant $ 22.54 $ 17.55  
Awards Outstanding [Roll Forward]      
Awards Outstanding (in number of shares) 2,979,933 3,599,169  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 390,780 615,089 757,603
Awards Forfeit and Expired (in number of shares) (17,103)    
Awards Exercised (in number of shares) (992,913)    
Awards Exercisable (in number of shares) 1,385,683    
Awards Outstanding, Weighted Average Exercise Price [Roll Forward]      
Awards Outstanding, Weighted Average Exercise Price $ 79.36 $ 69.07  
Grant price 119.86 $ 91.20  
Awards Forfeit and Expired, Weighted Average Exercise Price 91.98    
Awards Exercised, Weighted Average Exercise Price 57.49    
Awards Exercisable, Weighted Average Exercise Price $ 62.59    
Additional Disclosures [Abstract]      
Awards Outstanding, Weighted Average Remaining Contractual Term 6 years 4 months 24 days    
Awards Exercisable, Weighted Average Remaining Contractual Term 4 years 7 months 6 days    
Fair value of stock appreciation rights which became exerciable during the year $ 8,585 $ 8,611 $ 12,832
Awards Exercised, Total Intrinsic Value $ 55,031 $ 89,473 $ 101,365
Unvested Awards [Roll Forward]      
Awards Granted (in number of shares) 390,780 615,089 757,603
Unvested Awards, Weighted Average Grant Date Fair Value [Roll Forward]      
Fair value on date of grant $ 22.54 $ 17.55  
Unrecognized Compensation Cost [Abstract]      
Unrecognized Compensation Expense $ 8,746    
Unrecognized Compensation Expense, Period for Recognition 1 year 7 months 6 days    
Shares Granted to Directors [Abstract]      
Fair value on date of grant $ 22.54 $ 17.55  
Performance Shares [Member]      
Awards Granted, Fair Value Assumptions and Methodology [Abstract]      
Additional awards issued due to modification     26,316
Risk-free interest rate (in hundredths) 1.40%    
Dividend yield (in hundredths) 1.65%    
Expected life (in years) 2 years 10 months 24 days    
Volatility (in hundredths) 23.30%    
Grant price $ 119.86    
Fair value on date of grant $ 165.71    
Awards Outstanding [Roll Forward]      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 49,056 35,172 122,459
Awards Outstanding, Weighted Average Exercise Price [Roll Forward]      
Grant price $ 119.86    
Unvested Awards [Roll Forward]      
Awards Unvested (in number of shares) 77,979 137,809  
Awards Granted (in number of shares) 49,056 35,172 122,459
Awards Vested (in number of shares) (108,886)    
Unvested Awards, Weighted Average Grant Date Fair Value [Roll Forward]      
Awards Unvested, Weighted Average Grant Date Fair Value $ 138.14 $ 82.45  
Fair value on date of grant 165.71    
Awards Vested, Weighted Average Grant Date Fair Value $ 80.08    
Unrecognized Compensation Cost [Abstract]      
Unrecognized Compensation Expense $ 7,402    
Unrecognized Compensation Expense, Period for Recognition 1 year 9 months 18 days    
Shares Granted to Directors [Abstract]      
Performance Share Attainment   191.20% 186.10%
Fair value on date of grant $ 165.71    
Restricted Stock Units (RSUs) [Member]      
Awards Granted, Fair Value Assumptions and Methodology [Abstract]      
Additional awards issued due to modification     47,063
Fair value on date of grant $ 119.86 $ 91.20  
Awards Outstanding [Roll Forward]      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 83,512 124,929 284,721
Unvested Awards [Roll Forward]      
Awards Unvested (in number of shares) 252,907 324,553  
Awards Granted (in number of shares) 83,512 124,929 284,721
Forfeited awards (in number of shares) 11,140    
Awards Vested (in number of shares) (144,018)    
Unvested Awards, Weighted Average Grant Date Fair Value [Roll Forward]      
Awards Unvested, Weighted Average Grant Date Fair Value $ 93.43 $ 81.45  
Fair value on date of grant 119.86 91.20  
Awards Forfeit, Weighted Average Grant Date Fair Value 96.26    
Awards Vested, Weighted Average Grant Date Fair Value $ 81.16    
Unrecognized Compensation Cost [Abstract]      
Unrecognized Compensation Expense $ 14,943    
Unrecognized Compensation Expense, Period for Recognition 1 year 3 months 18 days    
Shares Granted to Directors [Abstract]      
Fair value on date of grant $ 119.86 91.20  
Minimum [Member] | Stock Appreciation Rights (SARs) [Member]      
Awards Granted, Fair Value Assumptions and Methodology [Abstract]      
Risk-free interest rate (in hundredths)     2.58%
Dividend yield (in hundredths)     1.99%
Expected life (in years)     5 years 7 months 6 days
Volatility (in hundredths)     20.95%
Grant price     $ 79.75
Fair value on date of grant     14.58
Awards Outstanding, Weighted Average Exercise Price [Roll Forward]      
Grant price     79.75
Unvested Awards, Weighted Average Grant Date Fair Value [Roll Forward]      
Fair value on date of grant     14.58
Shares Granted to Directors [Abstract]      
Fair value on date of grant     14.58
Minimum [Member] | Performance Shares [Member]      
Awards Granted, Fair Value Assumptions and Methodology [Abstract]      
Fair value on date of grant     79.75
Unvested Awards, Weighted Average Grant Date Fair Value [Roll Forward]      
Fair value on date of grant     79.75
Shares Granted to Directors [Abstract]      
Fair value on date of grant     79.75
Minimum [Member] | Restricted Stock Units (RSUs) [Member]      
Awards Granted, Fair Value Assumptions and Methodology [Abstract]      
Fair value on date of grant     79.75
Unvested Awards, Weighted Average Grant Date Fair Value [Roll Forward]      
Fair value on date of grant     79.75
Shares Granted to Directors [Abstract]      
Fair value on date of grant     $ 79.75
Maximum [Member] | Stock Appreciation Rights (SARs) [Member]      
Awards Granted, Fair Value Assumptions and Methodology [Abstract]      
Risk-free interest rate (in hundredths)     2.87%
Dividend yield (in hundredths)     2.43%
Expected life (in years)     5 years 8 months 12 days
Volatility (in hundredths)     21.20%
Grant price     $ 82.09
Fair value on date of grant     15.41
Awards Outstanding, Weighted Average Exercise Price [Roll Forward]      
Grant price     82.09
Unvested Awards, Weighted Average Grant Date Fair Value [Roll Forward]      
Fair value on date of grant     15.41
Shares Granted to Directors [Abstract]      
Fair value on date of grant     15.41
Maximum [Member] | Performance Shares [Member]      
Awards Granted, Fair Value Assumptions and Methodology [Abstract]      
Fair value on date of grant   91.20 82.09
Unvested Awards, Weighted Average Grant Date Fair Value [Roll Forward]      
Fair value on date of grant   91.20 82.09
Shares Granted to Directors [Abstract]      
Fair value on date of grant   $ 91.20 82.09
Maximum [Member] | Restricted Stock Units (RSUs) [Member]      
Awards Granted, Fair Value Assumptions and Methodology [Abstract]      
Fair value on date of grant     82.09
Unvested Awards, Weighted Average Grant Date Fair Value [Roll Forward]      
Fair value on date of grant     82.09
Shares Granted to Directors [Abstract]      
Fair value on date of grant     $ 82.09
Discontinued Operations [Member]      
Stock-based compensation expense [Abstract]      
Pre-tax compensation expense     $ 744